20 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Exploring S1 plasticity and probing S1' subsite of mammalian aminopeptidase N/CD13 with highly potent and selective aminobenzosuberone inhibitors.
University of Upper Alsace
Rapid and efficient synthesis of a novel series of substituted aminobenzosuberone derivatives as potent, selective, non-peptidic neutral aminopeptidase inhibitors.
University of Upper Alsace
Remarkable potential of thea-aminophosphonate/phosphinate structural motif in medicinal chemistry.
Wroclaw University of Technology
Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.
Mcgill University
N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity.
Sejong University
The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
Wroclaw University of Technology
Synthesis of sulfur-containing analogues of bestatin. Inhibition of aminopeptidases by alpha-thiolbestatin analogues.
University of Wisconsin
Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes.
TBA
A novel amino-benzosuberone derivative is a picomolar inhibitor of mammalian aminopeptidase N/CD13.
University of Upper Alsace
Amino-benzosuberone: a novel warhead for selective inhibition of human aminopeptidase-N/CD13.
Merck Sharpe and Dohme
New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13.
Wroclaw University of Technology
Individual stereoisomers of phosphinic dipeptide inhibitor of leucine aminopeptidase.
Wroclaw University of Technology
Molecular docking studies, biological and toxicity evaluation of dihydroisoquinoline derivatives as potential anticancer agents.
National Institute of Public Health-National Institute of Hygiene
Potent new leucine aminopeptidase inhibitor of novel structure synthesised by a modified Wadsworth-Emmons (Horner) Wittig procedure.
The Queen'S University of Belfast
Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme.
Pharmacia and Upjohn
Recent developments in the synthesis and applications of phosphinic peptide analogs.
Wroclaw University of Technology
Development of selective tight-binding inhibitors of leukotriene A4 hydrolase.
Scripps Research Institute
Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors
Centaurus Biopharma